Genomic Health (NASDAQ:GHDX) insider Kimberly J. Popovits sold 15,000 shares of the company’s stock in a transaction on Monday, April 16th. The stock was sold at an average price of $33.19, for a total transaction of $497,850.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Shares of GHDX traded down $0.22 during midday trading on Wednesday, hitting $32.53. 73,381 shares of the company traded hands, compared to its average volume of 189,671. Genomic Health has a 52 week low of $26.54 and a 52 week high of $37.50. The company has a market capitalization of $1,176.66, a PE ratio of 3,253.00 and a beta of 0.63.
Genomic Health (NASDAQ:GHDX) last released its quarterly earnings data on Thursday, March 8th. The medical research company reported $0.08 EPS for the quarter, missing the consensus estimate of $0.09 by ($0.01). Genomic Health had a negative net margin of 1.13% and a negative return on equity of 0.83%. The company had revenue of $87.50 million for the quarter, compared to the consensus estimate of $88.96 million. During the same period last year, the company earned $0.04 EPS. The firm’s revenue for the quarter was up 5.8% on a year-over-year basis. analysts forecast that Genomic Health will post 0.42 earnings per share for the current year.
Several large investors have recently made changes to their positions in the stock. Meeder Asset Management Inc. lifted its holdings in shares of Genomic Health by 120.7% in the 4th quarter. Meeder Asset Management Inc. now owns 2,960 shares of the medical research company’s stock valued at $101,000 after acquiring an additional 1,619 shares during the last quarter. New York State Common Retirement Fund lifted its holdings in shares of Genomic Health by 9.6% in the 3rd quarter. New York State Common Retirement Fund now owns 22,900 shares of the medical research company’s stock valued at $735,000 after acquiring an additional 2,000 shares during the last quarter. SG Americas Securities LLC lifted its holdings in shares of Genomic Health by 43.2% in the 3rd quarter. SG Americas Securities LLC now owns 8,769 shares of the medical research company’s stock valued at $281,000 after acquiring an additional 2,647 shares during the last quarter. Cornerstone Capital Management Holdings LLC. lifted its holdings in shares of Genomic Health by 22.5% in the 3rd quarter. Cornerstone Capital Management Holdings LLC. now owns 16,337 shares of the medical research company’s stock valued at $524,000 after acquiring an additional 3,000 shares during the last quarter. Finally, Cubist Systematic Strategies LLC bought a new position in shares of Genomic Health in the 3rd quarter valued at about $138,000. 89.99% of the stock is owned by hedge funds and other institutional investors.
Several research analysts have commented on the stock. BidaskClub downgraded shares of Genomic Health from a “buy” rating to a “hold” rating in a report on Wednesday, April 11th. ValuEngine downgraded shares of Genomic Health from a “hold” rating to a “sell” rating in a report on Thursday, March 1st. Canaccord Genuity reissued a “buy” rating and set a $42.00 price objective on shares of Genomic Health in a report on Tuesday, January 16th. Piper Jaffray reissued a “hold” rating and set a $33.00 price objective on shares of Genomic Health in a report on Thursday, March 8th. Finally, Zacks Investment Research raised shares of Genomic Health from a “sell” rating to a “hold” rating in a report on Tuesday, February 13th. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating and one has given a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $32.67.
WARNING: This news story was first reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this news story on another site, it was illegally copied and reposted in violation of US and international trademark & copyright laws. The correct version of this news story can be viewed at https://ledgergazette.com/2018/04/18/kimberly-j-popovits-sells-15000-shares-of-genomic-health-ghdx-stock.html.
About Genomic Health
Genomic Health, Inc, a healthcare company, provides actionable genomic information to personalize cancer treatment decisions worldwide. It develops and commercializes genomic-based clinical laboratory services that analyze the underlying biology of cancer, allowing physicians and patients to make individualized treatment decisions.
Receive News & Ratings for Genomic Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genomic Health and related companies with MarketBeat.com's FREE daily email newsletter.